U.S. Biotech Stock News

AeroVironment (NasdaqGS:AVAV) recently featured on a major U.S. news program for its laser defense systems aimed at countering international drone threats. The company secured more than US$1b in new long term defense contracts, significantly expanding its backlog. These wins arrived alongside a record goodwill impairment and financial guidance that some investors viewed as underwhelming. AeroVironment is best known for unmanned aerial systems, and its advanced laser defense technology...

Pathward Financial recently reported a softer quarter in which revenue and net interest income came in below analysts’ expectations, prompting investors to reassess its recent performance. Despite the miss, CEO Brett Pharr reiterated confidence in Pathward’s banking‑as‑a‑service strategy and signaled an emphasis on sustainable growth heading into fiscal 2026. We’ll now examine how the earnings miss, alongside management’s reaffirmed confidence, may reshape Pathward Financial’s longer-term...

If you are wondering whether Regeneron Pharmaceuticals at around US$732.87 is still offering value or starting to look expensive, you are asking the right question. The stock has seen mixed returns, with an 11.9% gain over the last year but declines of 1.7% over the past week, 6.3% over the past month, and 5.6% year to date. These moves can change how the market views its growth potential and risk. Recent coverage of Regeneron Pharmaceuticals has kept attention on the business and its...

Investors may be wondering whether Urban Outfitters, at around US$63 a share, is still a sensible entry point or addition to a portfolio, or if the easy value has already been taken. The stock is up 29.0% over the last year and 139.1% over three years, even though it is 15.9% lower year to date and 9.6% lower over the last month. Recent coverage has focused on Urban Outfitters as a specialty retail name that has attracted attention after a strong multi year run. More recent pullbacks have...

If you are wondering whether McKesson at around US$885.84 is still offering fair value or starting to look stretched, this article walks through the key numbers that matter. The stock price has moved by a 5.9% decline over the past week and a 6.5% decline over the past month, set against a 7.6% gain year to date and a 34.5% return over the last year, which may have shifted how the market is thinking about its risk and reward profile. Recent headlines around McKesson have focused on its role...

Why Parker-Hannifin (PH) is on investors’ radar today Parker-Hannifin (PH) has drawn fresh attention after a mixed stretch in its share performance, with a 10.33% decline over the past month contrasted by a 2.24% gain in the past 3 months. See our latest analysis for Parker-Hannifin. At a share price of $894.41, Parker-Hannifin’s recent 1 day and 30 day share price declines sit against a much stronger 1 year and multi year total shareholder return. This suggests that momentum has cooled after...

Bright Horizons Family Solutions (BFAM) is in the spotlight after announcing plans to close 45 to 50 underperforming centers in 2026, while investigations begin and management leans harder into its higher margin back up care business. See our latest analysis for Bright Horizons Family Solutions. Those center closures and the fresh securities investigations come after a sharp reset in sentiment. A 30 day share price return of 9.12% contrasts with a 90 day share price return decline of 23.91%...

Western Digital (WDC) has been caught in a sharp pullback as Middle East tensions, higher oil prices, and fresh US charges tied to AI chip smuggling ripple through high-growth technology names. See our latest analysis for Western Digital. The latest pullback comes after Western Digital’s share price climbed sharply, with a 90 day share price return of 61.86% and a very large 1 year total shareholder return that points to powerful, but volatile, momentum. If the recent swings in storage and AI...

Recent performance snapshot for Definium Therapeutics (DFTX) Definium Therapeutics (NasdaqGS:DFTX) has drawn attention after a past 3 months total return of 44.9% and a 1 year total return above 100%. This has prompted closer scrutiny of its clinical stage risk and valuation. See our latest analysis for Definium Therapeutics. The recent 90 day share price return of 44.9% and very large 3 year total shareholder return suggest momentum has been building, even though the latest 1 day move showed...

What the recent share performance signals for Bath & Body Works (BBWI) Recent trading in Bath & Body Works (BBWI) has drawn attention, with the stock showing a 4.5% decline over the past day and a month return of about 18.8% lower, alongside weaker past year and 3 year total returns. See our latest analysis for Bath & Body Works. The recent 30 day share price return of 18.8% lower and 1 year total shareholder return of 33.6% lower suggest momentum has been weak, as the current share price of...

Citizens recently reaffirmed its positive view on Xometry (XMTR) after the company announced a leadership change, with co founder and CEO Randy Altschuler moving to executive chairman and president Sanjeev Singh Sahni set to become CEO. See our latest analysis for Xometry. The leadership transition headlines come after a sharp 37.5% year to date share price decline to US$39.20 and a 32% 30 day share price pullback. However, the 1 year total shareholder return of 52.4% and 3 year total...

If you are wondering whether CACI International's share price still offers value after a strong run, this breakdown will help you frame that question using several valuation lenses. The stock last closed at US$606.38, with returns of 6.9% over 30 days, 12.8% year to date, 65.6% over 1 year, 110.8% over 3 years, and 151.0% over 5 years. This naturally raises questions about what is already reflected in the price. Recent news coverage has focused on CACI International in the context of its...

Agilysys stock: context for recent performance Agilysys (AGYS) has drawn investor attention after recent share price moves, with the stock showing mixed returns over the past month and past 3 months while longer term performance remains varied. See our latest analysis for Agilysys. At a share price of US$70.81, Agilysys has seen a 1-day share price return of 1.80% and a 7-day share price return of 3.39%, set against a 90-day share price return of 41.72% and a 1-year total shareholder return...

Earlier in March, the California Public Utilities Commission issued a proposed decision on California Water Service’s 2024 General Rate Case, outlining rate increases through 2028 and reauthorizing key revenue adjustment and cost recovery mechanisms. This proposal, alongside mechanisms that help decouple revenue from actual water sales, could materially influence the stability and predictability of California Water Service Group’s future cash flows. We’ll now examine how the proposed...

Wondering whether Freshworks is starting to look like value or a value trap? This article breaks down what the current share price might really be offering you. The stock last closed at US$8.03, with returns of 8.2% over 30 days but a 48.3% decline over the past year that may have changed how investors view its risk and reward profile. Recent coverage has focused on Freshworks as a mid cap software name that is still trying to win investor confidence after a 30.8% year to date decline and a...

AAR Corp (AIR) has been drawing investor attention after recent trading that left the shares around $101.33, with returns over the past month and the past 3 months moving in sharply different directions. See our latest analysis for AAR. That 7.22% one day drop and 11.60% 30 day share price return pullback comes after a 22.51% 90 day share price return and a 49.17% 1 year total shareholder return. This suggests momentum has cooled recently following a strong longer term run. If you are...

Why NOV (NOV) is on investors’ radar today NOV (NOV) has drawn fresh attention after recent share performance showed a 1 day gain of 0.48%, a 0.36% move over the past week, and a 6.55% decline over the past month. See our latest analysis for NOV. Against this backdrop, NOV’s recent pullback over the past month comes after a stronger 90 day share price return of 19.21% and a 1 year total shareholder return of 32.58%. Together, these figures point to momentum that has cooled in the very near...

Why Dow Stock Is On Investors’ Radar Today Dow (DOW) has drawn fresh attention after recent trading left the shares with a 16% gain over the past month and a 58% gain over the past 3 months, prompting investors to reassess the chemicals group’s value profile and recent financial results. See our latest analysis for Dow. With the share price at $36.65, Dow’s recent 30 day share price return of 16.1% and 90 day share price return of 57.6% sit against a 1 year total shareholder return of 8.2%...

In recent days, Halliburton, working with ExxonMobil, Sekal, Noble and the Wells Alliance Guyana team, completed the industry’s first fully automated geological well placement with complete rig automation offshore Guyana, improving well construction performance and execution efficiency. At the same time, Iranian strikes on Qatar’s Ras Laffan LNG complex and ExxonMobil-linked facilities in the Gulf have tightened global gas and oil supply, highlighting both the company’s operational exposure...

In the past quarter, BJ's Wholesale Club reported revenue roughly in line with expectations but fell short on EBITDA and lowered its full-year EPS guidance. This combination of steady sales but weaker profitability signals that cost pressures and operational efficiency, rather than demand, are currently the key pressure points for the business. Next, we’ll explore how the weaker EBITDA and reduced EPS outlook may affect BJ’s longer-term investment narrative and assumptions. Invest in the...

Earlier this year, United Airlines began selling seats on its upgraded Boeing 787-9 Dreamliner with the new United Elevated interior and Polaris Studio suites, ahead of the inaugural UA1 international flight from San Francisco to Singapore on April 22. This move signals a significant push to enhance United's long-haul premium experience and deepen its commitment to higher-end, experience-focused international travel. Next, we'll examine how this new premium 787-9 cabin rollout could reshape...

If you are wondering whether Coterra Energy's current share price reflects its underlying worth, this breakdown is designed to help you connect the recent share moves with what the fundamentals may be implying. Coterra's stock last closed at US$33.97, with returns of 5.7% over 7 days, 7.9% over 30 days, 27.7% year to date, 22.3% over 1 year, 58.0% over 3 years and 129.9% over 5 years. These figures can influence how the current balance between risk and potential reward feels to investors...

XPeng (NYSE:XPEV) closed FY 2025 with fourth quarter revenue of C¥22.3b and basic EPS of C¥0.40, while trailing twelve month figures show total revenue of C¥76.7b and a basic EPS loss of C¥1.20, keeping the story firmly focused on scale over the bottom line. The company’s quarterly revenue moved from C¥10.1b in Q3 2024 to C¥22.3b in Q4 2025, with basic EPS shifting from a C¥1.91 loss to C¥0.40, so the latest results sit against a backdrop of expanding sales and still thin margins that...

Earlier this week, an analyst at UBS upgraded Knight-Swift Transportation Holdings after observing signs of a tightening truckload market, including fewer new commercial driver licenses since late 2025. This shift in labor supply highlights how changes in driver availability can influence expectations for freight capacity, pricing power, and earnings for large carriers like Knight-Swift. Next, we’ll explore how the apparent tightening in truckload capacity interacts with Knight-Swift’s...